A consensus-based guideline for personalized bacteriophage therapy - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Guidelines for Tailored Bacteriophage Therapy Based on Expert Consensus

  • By

  • Silvia Würstle

  • Simone C. Lieberknecht-Jouy

  • Anja Düchting

  • Holger Lößner

  • Pieter-Jan Ceyssens

  • Jean-Paul Pirnay

  • Mathieu de Jode

  • Shawna McCallin

  • Lorenz Leitner

  • Christian Willy

  • Sebastian Leptihn

  • Imke Korf

  • Evgeny A. Idelevich

  • Martin Witzenrath

  • Timo Faltus

  • Peter Ruth

  • Henning Blume

  • Manuel Cornely

  • Helmut Fickenscher

  • Mathias W. Pletz

  • Sylvia Hafkemeyer

  • Christine Rohde

  • Oleg Krut

  • Wolfgang Beyer

  • Oliver Hartwich

  • Ulrich Matt

  • Rebecca L. Knoll

  • Münevver Demir

  • Jens Hammerl

  • Stefanie Barbirz

  • Mirjam Stahl

  • Renate Krüger

  • Joachim Bugert

  • Melanie Kempe

  • Paul E. Turner

  • Benjamin Chan

  • Tristan Ferry

  • Maria J. G. T. Vehreschild

  • Annika Y. Classen

  • September 21, 2026

Share

  • 1

    The guideline provides consensus-based recommendations for personalized bacteriophage therapy to address antimicrobial resistance.

  • 2

    An interdisciplinary expert group developed the guideline, ensuring inclusivity and relevance to clinical and societal needs.

  • 3

    The recommendations cover phage therapy principles, preparation standards, clinical administration, and future research priorities.

  • 4

    The guideline applies from January 5, 2026, to June 29, 2030, with annual assessments for potential updates.

  • 5

    It targets a wide audience, including physicians, pharmacists, researchers, and policymakers involved in infectious disease management.

Original Source(s)

A consensus-based guideline for personalized bacteriophage therapy

  • by Silvia Würstle, Simone C. Lieberknecht-Jouy, Anja Düchting, Holger Lößner, Pieter-Jan Ceyssens, Jean-Paul Pirnay, Mathieu de Jode, Shawna McCallin, Lorenz Leitner, Christian Willy, Sebastian Leptihn, Imke Korf, Evgeny A. Idelevich, Martin Witzenrath, Timo Faltus, Peter Ruth, Henning Blume, Manuel Cornely, Helmut Fickenscher, Mathias W. Pletz, Sylvia Hafkemeyer, Christine Rohde, Oleg Krut, Wolfgang Beyer, Oliver Hartwich, Ulrich Matt, Rebecca L. Knoll, Münevver Demir, Jens Hammerl, Stefanie Barbirz, Mirjam Stahl, Renate Krüger, Joachim Bugert, Melanie Kempe, Paul E. Turner, Benjamin Chan, Tristan Ferry, Maria J. G. T. Vehreschild, Annika Y. Classen

  • September 21, 2026

Related Content

Musings from The Power List: Ali Tavassoli

Ali Tavassoli explains how cyclic peptides and new discovery tools are opening up once-inaccessible biology

Correction to: Coronary microvascular function in patients with sepsis and myocardial injury: an invasive coronary physiology study

Errors in Figure Keys

  • September 11, 2026